Anavex Life Sciences Market Cap

Anavex Life Sciences has a market cap or net worth of 524.37 million as of May 15, 2025. Its market cap has increased by 119.59% in one year.

Market Cap

524.37M

Enterprise Value

437.33M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

8.10

Market Cap Chart

Since April 13, 2006, Anavex Life Sciences's market cap has increased from 182.56K to 524.37M, an increase of 287,135.49%. That is a compound annual growth rate of 51.73%.

Market Cap History

Date	Market Cap	% Change
May 14, 2025	524.37M	-27.93%
Dec 31, 2024	727.61M	21.27%
Dec 29, 2023	599.98M	0.14%
Dec 30, 2022	599.16M	-38.45%
Dec 31, 2021	973.48M	267.56%
Dec 31, 2020	264.85M	141.31%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	155.40B
GSK plc	55.27B
Haleon	35.54B
Smith & Nephew	9.24B
ConvaTec Group	5.43B
Hikma Pharmaceuticals	4.28B
HUTCHMED (China)	1.79B
Genus	1.38B

Market Cap Rankings